Merck KGaA (Germany), Thermo Fisher Scientific, Inc. (US) and QIAGEN N.V. (Netherlands) are Leading Players in the Oxidative Stress Assay Market
The global oxidative stress assay market is projected to reach USD 1,326 million by 2025 from USD 836 million in 2020, at a CAGR of 9.7%. Growth in this market is mainly driven by growth in the biopharmaceutical industry and increasing public-sector funding for academic research. Other important factors aiding the growth of this market include technological advancements like HCS for drug discovery, increasing R&D expenditure in biotechnology and pharmaceutical industries, and government support for pharmaceutical and biotechnology industries. On the other hand, the high cost of instruments and shortage of trained and qualified personnel are the major factors restraining the growth of this market.
The major players in the oxidative stress assay market are Abcam, plc (UK), Enzo Biochem, Inc. (US), Merck KGaA (Germany), QIAGEN N.V. (Netherlands), Thermo Fisher Scientific, Inc. (US), AMS Biotechnology (Europe), Ltd. (UK), BioVision, Inc. (US), Cell Biolabs, Inc. (US), Oxford Biomedical Research (US), Promega Corporation (US), Cayman Chemical (US), Eagle Biosciences, Inc. (US), Arbor Assays (US), Hycult Biotech (Netherlands), Callegari SRL (Italy), Kamiya Biomedical Company (US), MEGA TIP San.Tic.Ltd.Sti. (Turkey), ImmunoChemistry Technologies, LLC (US), Genox Corporation (US), and Toxys B.V. (Netherlands). Analysis of the market developments between 2017 and 2020 revealed that partnerships & agreements, product launches, and strategic acquisitions were adopted by market players to strengthen their product portfolios and maintain a competitive position in the oxidative stress assay market.
To know about the assumptions considered for the study download the pdf brochure
Merck KGaA (Germany)
The company was the largest player in the oxidative stress assays market, in 2019. Merck has a strong financial performance with a risk diversified business portfolio. The company has a strong focus on R&D and has invested 14% or more of its revenue on R&D over the last three years. Merck also has a robust product portfolio, along with a strong geographic presence and brand name. These factors make Merck a dominant player and market leader in the oxidative stress assays market. The company further strengthened its position in the oxidative stress assays market with the acquisition of Sigma-Aldrich in 2015.
Thermo Fisher Scientific, Inc. (US)
Thermo Fisher was the second-largest player in the oxidative stress assays market, in 2019. The company focuses on expanding its presence in the oxidative stress assays market by investing in research and development activities. This helps the company to launch new products in the market. For instance, in February 2015, the company launched the Varioskan LUX multimode microplate reader, which helps simplify data acquisition and analysis and improves reliability in assay results. Furthermore, the company has a strong presence in emerging markets, a good online presence, and is driven by innovation to strengthen its position in the oxidative stress assays market.
QIAGEN N.V. (Netherlands)
QIAGEN N.V. was the third-largest player in the oxidative stress assays market, in 2019. QIAGEN N.V. has numerous strengths that enable it to thrive in the marketplace. These strengths not only help it to protect its market share in existing markets but also help it in penetrating new markets. QIAGEN N.V. is investing huge resources in the training and development of its employees, which is resulting in a workforce that is highly skilled. Moreover, the company has a strong dealer community; it has built a culture among distributors and dealers where the dealers not only promote the company’s products but also invest in training their sales teams to explain how customers can extract the maximum benefits out of their products.
Related Reports:
Oxidative Stress Assay Market by Product (Consumable, Instruments, Kits, Services), Test Type (Indirect, nucleic acid, Glutathione, ROS), Technology (ELISA, Chromatography), Diseases (CVD, Oncology) End Users (Pharma & Biotech) - Global Forecasts to 2025
Contact:
Mr. Aashish Mehra
MarketsandMarkets™ INC.
630 Dundee Road
Suite 430
Northbrook, IL 60062
USA : 1-888-600-6441
[email protected]
This FREE sample includes market data points, ranging from trend analyses to market estimates & forecasts. See for yourself.
SEND ME A FREE SAMPLE
